A planning committee of the National Academies of Sciences, Engineering, and Medicine will plan and host a 1.5-day public workshop that will examine the array of short- and long-term toxicities and adverse effects that patients may experience as a result of cancer treatment and consider options to improve quality of life for cancer survivors and their families by addressing these adverse consequences. The workshop will feature invited presentations and panel discussions on topics that may include:

• An overview of the physical and mental health risks and socioeconomic consequences of cancer diagnosis and treatment, including unique considerations for different patient populations (e.g., children or older adults).
• Strategies to better accrue data on short- and long-term effects of cancer and cancer treatment, as captured by patient-reported outcome measures, clinician input, or other methods.
• Opportunities to redesign cancer treatment approaches to reduce short- and long-term toxicities without compromising treatment effectiveness, as well as strategies to mitigate toxicities that may occur.
• Patient engagement in treatment decision-making and tools to aid their assessment of the various risk/benefit tradeoffs.
• System-level interventions, best practices and low tech/low cost approaches to prevention, surveillance, and mitigation of cancer treatment–related toxicities and adverse effects.
• Opportunities to overcome the challenges that prevent uptake and dissemination of evidence-based approaches to address treatment-related toxicities and adverse effects.

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.